Imagyn licenses MicroSpan line to Ethicon:
This article was originally published in Clinica
Executive Summary
Imagyn Medical Technologies is to license its MicroSpan microhysteroscopy product line to Ethicon. Under the terms of the agreement, which includes cash payments of $4 million with certain milestones, Imagyn, of Newport Beach, California, will initially supply the products to Ethicon for up to two years on an exclusive basis. Ethicon will have a worldwide, exclusive licence to manufacture and market the products for ten years. After this time, Somerville, New Jersey-based Ethicon will own the products. Imagyn recently announced the divestiture of its impotence product lines to Timm Research for $25.8 million. The company is looking at options - including sale or alliances - for its remaining non-strategic assets.